News & Events
-
April 11, 2018 - April 12, 2018
2018 Annual International Neonatal Scientific Workshop
Bethesda North Marriott Hotel & Conference Center, Maryland Agenda – Day 1, April 11, 2018 8:00 am – 12:00 pm INC Hemodynamic Adaptation Workgroup Meeting Heike Rabe and Janis Dionne, co-chairs 8:00 am – 12:00 pm INC BPD Workgroup Meeting Robin Steinhorn and Wolfgang Göpel, co-chairs 12:00 pm – 1:00 pm Lunch 1:00 pm... -
March 28, 2018
C-Path and CHDI launch consortium to accelerate development of Huntington’s disease therapies
Tucson, AZ, and New York, NY – March 28, 2018 – The Critical Path Institute (C-Path), together with CHDI Foundation, Inc. (CHDI), today announced the official launch of C-Path’s Huntington’s Disease Regulatory Science Consortium (HD-RSC). In addition to these cofounders, the consortium also includes more than 20 different member organizations, including industry partners,... -
March 24, 2018
Global Health Partners Accelerate Uptake of Genetic Sequencing for Surveillance And Diagnosis Of Drug-Resistant Tuberculosis
WHO adopts ReSeqTB as bioinformatics platform for TB surveillance, enabling the global scale-up of culture-free, drug-resistant Mycobacterium tuberculosis surveillance programs based on sequencing technologies Renewed funding from the Bill & Melinda Gates Foundation has been applied for to support FIND, C-Path, and WHO to take ReSeqTB to the next level as part... -
March 14, 2018
Towards Bridging Translational Gap in Cardiotoxicity Prediction: an Application of Progressive Cardiac Risk Assessment Strategy in TdP Risk Assessment of Moxifloxacin
Patel N, Hatley O, Berg A, Romero K, Wisniowska B, Hanna D, et al. Towards Bridging Translational Gap in Cardiotoxicity Prediction: an Application of Progressive Cardiac Risk Assessment Strategy in TdP Risk Assessment of Moxifloxacin. AAPS J. 2018 May 1;20(3):47.
- March 11, 2018
